Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Spectral AI Inc WT (MDAIW)

Spectral AI Inc WT (MDAIW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Spectral AI Names Vincent S. Capone as Chief Executive Officer

DALLAS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster...

MDAIW : 0.4702 (+4.49%)
MDAI : 1.6115 (+3.97%)
Spectral AI to Participate in National Burn Awareness Week 2026 February 1–7, 2026

DALLAS, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster...

MDAIW : 0.4702 (+4.49%)
MDAI : 1.6115 (+3.97%)
DeepView™ System Featured at 2025 US Burn Conferences

DALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster...

MDAIW : 0.4702 (+4.49%)
MDAI : 1.6115 (+3.97%)
Spectral AI Announces 2025 Third Quarter Financial Results

Q3 Overview Research & Development Revenue of $3.8 Million; $15.6 Million in YTD Revenue for 2025 Strong Cash position of $10.5 Million and progress toward FDA De Novo submission DALLAS, Nov....

MDAIW : 0.4702 (+4.49%)
MDAI : 1.6115 (+3.97%)
Spectral AI Schedules 2025 Third Quarter Financial Results and Conference Call

DALLAS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster...

MDAIW : 0.4702 (+4.49%)
MDAI : 1.6115 (+3.97%)
Spectral AI raises $7.6 Million of Additional Growth Capital

DALLAS, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster...

MDAIW : 0.4702 (+4.49%)
MDAI : 1.6115 (+3.97%)
Spectral AI Named to TIME’s List of World’s Top HealthTech Companies 2025

DALLAS, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster...

MDAIW : 0.4702 (+4.49%)
MDAI : 1.6115 (+3.97%)
DeepView® System highlighted at the European Burns Association Congress

DALLAS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster...

MDAIW : 0.4702 (+4.49%)
MDAI : 1.6115 (+3.97%)
Spectral AI Announces 2025 Second Quarter Financial Results

Q2 Overview Research & Development Revenue of $5.1 Million, total revenue for the first half of 2025 of $11.8 Million Strong Cash position of $10.5 Million Submission of De Novo application to...

MDAIW : 0.4702 (+4.49%)
MDAI : 1.6115 (+3.97%)
Spectral AI Schedules 2025 Second Quarter Financial Results and Conference Call

DALLAS, July 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”) , developer of the AI-driven DeepView ® System and focused on medical diagnostics for...

MDAIW : 0.4702 (+4.49%)
MDAI : 1.6115 (+3.97%)

Barchart Exclusives

No Bottom in Sight: Wall Street Wants You to Sell QCOM Stock After Earnings
Qualcomm’s post‑earnings drop back to 2020 price levels, a 2026 EPS decline, and handset‑heavy exposure have rekindled “no bottom in sight” doubts even as the stock screens cheap at 14× forward earnings and still carries a "Moderate Buy" rating with roughly 22% implied upside. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar